Classification of high-grade endometrium carcinomas using molecular and immunohistochemical methods.

The use of molecular classification in the clinical practice will allow more accurate prognostic prediction and more appropriate treatment planning, particularly as high-grade ECs constitute a heterogenous group with poor prognosis.